By means of CRISPR screening, LMU researchers have provided the first ever comprehensive molecular characterization of T cell infiltration into the central nervous system of people with MS.
Inovio spinout plans pivotal study for cancer vaccine as it touts alternative take on PhIb/IIa liver cancer data
Inovio spinout Geneos Therapeutics said Tuesday that it has three new partial responses and one case of stable disease from a mid-stage liver cancer trial
August 23, 2023